These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 9397428)
21. Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary to NMDA receptor antagonism with a low dose of amantadine. Deep P; Dagher A; Sadikot A; Gjedde A; Cumming P Synapse; 1999 Dec; 34(4):313-8. PubMed ID: 10529725 [TBL] [Abstract][Full Text] [Related]
22. Striatal dopamine during sensorial stimulations: a [18F]FDOPA PET study in human and cats. Hassoun W; Thobois S; Ginovart N; Garcia-Larrea L; Cavorsin ML; Guillouet S; Bonnefoi F; Costes N; Lavenne F; Martin JP; Broussolle E; Leviel V Neurosci Lett; 2005 Jul 22-29; 383(1-2):63-7. PubMed ID: 15936513 [TBL] [Abstract][Full Text] [Related]
23. Striatal kinetic modeling of FDOPA with a cerebellar-derived constraint on the distribution of volume of 30MFD: a PET investigation using non-human primates. Shoghi-Jadid K; Huang SC; Stout DB; Yee RE; Yeh EL; Farahani KF; Satyamurthy N; Phelps ME; Barrio JR J Cereb Blood Flow Metab; 2000 Jul; 20(7):1134-48. PubMed ID: 10908046 [TBL] [Abstract][Full Text] [Related]
24. Role of the dopaminergic system in chronic pain -- a fluorodopa-PET study. Jääskeläinen SK; Rinne JO; Forssell H; Tenovuo O; Kaasinen V; Sonninen P; Bergman J Pain; 2001 Feb; 90(3):257-260. PubMed ID: 11207397 [TBL] [Abstract][Full Text] [Related]
25. Striatal dopaminergic denervation in pallidopyramidal disease demonstrated by positron emission tomography. Remy P; Hosseini H; Degos JD; Samson Y; Agid Y; Warter JM; Vidailhet M Ann Neurol; 1995 Dec; 38(6):954-6. PubMed ID: 8526470 [TBL] [Abstract][Full Text] [Related]
26. Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Hilker R; Schweitzer K; Coburger S; Ghaemi M; Weisenbach S; Jacobs AH; Rudolf J; Herholz K; Heiss WD Arch Neurol; 2005 Mar; 62(3):378-82. PubMed ID: 15767502 [TBL] [Abstract][Full Text] [Related]
27. L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography. Melega WP; Grafton ST; Huang SC; Satyamurthy N; Phelps ME; Barrio JR J Cereb Blood Flow Metab; 1991 Nov; 11(6):890-7. PubMed ID: 1939384 [TBL] [Abstract][Full Text] [Related]
29. Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ma Y; Feigin A; Dhawan V; Fukuda M; Shi Q; Greene P; Breeze R; Fahn S; Freed C; Eidelberg D Ann Neurol; 2002 Nov; 52(5):628-34. PubMed ID: 12402261 [TBL] [Abstract][Full Text] [Related]
30. Methods for improving quantitation of putamen uptake constant of FDOPA in PET studies. Yu DC; Huang SC; Grafton ST; Melega WP; Barrio JR; Mazziotta JC; Phelps ME J Nucl Med; 1993 Apr; 34(4):679-88. PubMed ID: 8455088 [TBL] [Abstract][Full Text] [Related]
31. Reproducibility of fluorine-18-6-fluorodopa positron emission tomography in normal human subjects. Vingerhoets FJ; Snow BJ; Schulzer M; Morrison S; Ruth TJ; Holden JE; Cooper S; Calne DB J Nucl Med; 1994 Jan; 35(1):18-24. PubMed ID: 8285951 [TBL] [Abstract][Full Text] [Related]
32. Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia. Hietala J; Syvälahti E; Vilkman H; Vuorio K; Räkköläinen V; Bergman J; Haaparanta M; Solin O; Kuoppamäki M; Eronen E; Ruotsalainen U; Salokangas RK Schizophr Res; 1999 Jan; 35(1):41-50. PubMed ID: 9988840 [TBL] [Abstract][Full Text] [Related]